Temporary pupil rings useful in complicated MICS

Article

The use of temporary pupil rings for pupil dilation during microincision cataract surgery (MICS) is particularly useful in cases with floppy iris syndrome.

The use of temporary pupil rings for pupil dilation during microincision cataract surgery (MICS) is particularly useful in cases with floppy iris syndrome, according to Boris Malyugin from the S. Fyodorov Eye Microsurgery Complex, Moscow, Russia.

Dr Malyugin and co-workers developed a new temporary pupillary ring that uses the scroll principle of iris margin capture. A total of 59 MICS procedures were carried out in subjects with cataract complicated by glaucoma, pseudoexfoliative syndrome, diabetes and uveitis. Procedures were performed using a 2.2 mm wide incision coaxial MICS. In the control group (32 eyes), conventional iris hooks were used while, in the study group (27 eyes), the temporary pupil expander rings were used.

Intra- and postoperative complications were comparable, with slightly fewer noted in the study group.

The results demonstrated that the temporary pupil ring offered superior endothelial cell protection and decreased hyphemas, fibrinoid reactions and early postoperative hypertension.

The researchers concluded that the use of the temporary pupil ring is a reasonable option for pupil dilation during MICS especially in the cases with floppy iris syndrome.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.